Phase ? HL-1186 dominant dose group:HL-1186 tablets were taken orally, and then HL-1186 mimics or HL-1186 tablets were taken orally every 6 hours for a total of 8 times

To evaluate the efficacy and safety of HL-1186 tablets for abdominal postoperative analgesia in a multicenter, randomized, double-blind, placebo-positive parallel controlled phase ?/? clinical trial

To evaluate the efficacy and safety of HL-1186 tablets for orthopedic postoperative analgesia in a multicenter, randomized, double-blind, placebo-positive parallel controlled phase ?/? clinical trial